Accueil   Diary - News   All news Theranexus, Lyon Neuroscience Research Center and CERMEP announce the creation and funding of new joint public/private laboratory “NEUROIMAGING FOR DRUG DISCOVERY” (NI2D)

Theranexus, Lyon Neuroscience Research Center and CERMEP announce the creation and funding of new joint public/private laboratory “NEUROIMAGING FOR DRUG DISCOVERY” (NI2D)

 

The laboratory obtained funding of €350,000 from the French National Research Agency (ANR).
 

 

Lyon, 18 December 2020 – Theranexus, a biopharmaceutical company innovating in the treatment of neurological diseases has announced the creation and funding of a new joint public/private laboratory in partnership with the BIORAN team from the Lyon Neuroscience Research Center (CRNL) and CERMEP (Hospices Civils de Lyon, Claude Bernard Lyon 1 University, INSERM, CNRS), the regional biomedical imaging core dedicated to clinical and basic research.

 


This laboratory, “NeuroImaging for Drug Discovery (NI2D)”, aims to improve understanding of the cellular and molecular mechanisms of drug candidates developed by Theranexus – in particular at the neuronal and astrocyte level – using novel preclinical neuroimaging tools.

 

 

Read the press release